| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.26 | 0.08 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |